A novel p53-binding domain in CUL7

Biochemical and Biophysical Research Communications

Volumn 348, Issue 1, 2006, Pages 132-138

  Kasper, Jocelyn S ^a,c   Arai, Takehiro ^a,b,c   DeCaprio, James A ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CUL7; Cullin RING ligase; p53; PARC; Sequence homology; SKP cullin F box; Tumor suppressors; Ubiquitin protein ligases

Indexed keywords

PROTEIN; PROTEIN CUL7; PROTEIN HERC2; PROTEIN P53; PROTEIN PARC; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BINDING SITES; CARRIER PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CULLIN PROTEINS; HUMANS; MICE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES;

EID: 33746679135     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.07.013     Document Type: Article

References (38)

1. Hollstein M., Sidransky D., Vogelstein B., and Harris C.C. p53 mutations in human cancers. Science 253 (1991) 49-53
2. Yu J., Zhang L., Hwang P.M., Rago C., Kinzler K.W., and Vogelstein B. Identification and classification of p53-regulated genes. Proc. Natl. Acad. Sci. USA 96 (1999) 14517-14522
3. Zhao R., Gish K., Murphy M., Yin Y., Notterman D., Hoffman W.H., Tom E., Mack D.H., and Levine A.J. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev. 14 (2000) 981-993
4. el-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75 (1993) 817-825
5. Fang S., Jensen J.P., Ludwig R.L., Vousden K.H., and Weissman A.M. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. J. Biol. Chem. 275 (2000) 8945-8951
6. Jimenez G.S., Khan S.H., Stommel J.M., and Wahl G.M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18 (1999) 7656-7665
7. Jackson P.K., and Eldridge A.G. The SCF ubiquitin ligase: an extended look. Mol. Cell 9 (2002) 923-925
8. Scheffner M., and Howley P.M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. USA 91 (1994) 8797-8801
9. Zheng N., Schulman B.A., Song L., Miller J.J., Jeffrey P.D., Wang P., Chu C., Koepp D.M., Elledge S.J., Pagano M., Conaway R.C., Conaway J.W., Harper J.W., and Pavletich N.P. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416 (2002) 703-709
10. Geyer R.K., Yu Z.K., and Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2 (2000) 569-573
11. Haupt Y., Maya R., Kazaz A., and Oren M. Mdm2 promotes the rapid degradation of p53. Nature 387 (1997) 296-299
12. Kubbutat M.H., Jones S.N., and Vousden K.H. Regulation of p53 stability by Mdm2. Nature 387 (1997) 299-303
13. Freedman D.A., Wu L., and Levine A.J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55 (1999) 96-107
14. Boyd S.D., Tsai K.Y., and Jacks T. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2 (2000) 563-568
15. Ciechanover A., and Schwartz A.L. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22 (2000) 442-451
16. Dias D.C., Dolios G., Wang R., and Pan Z.Q. CUL7: a DOC domain-containing cullin selectively binds Skp1.Fbx29 to form an SCF-like complex. Proc. Natl. Acad. Sci. USA 99 (2002) 16601-16606
17. Arai T., Kasper J.S., Skaar J.R., Ali S.H., Takahashi C., and DeCaprio J.A. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 9855-9860
18. Daud A.I., Lanson Jr. N.A., Claycomb W.C., and Field L.J. Identification of SV40 large T-antigen-associated proteins in cardiomyocytes from transgenic mice. Am. J. Physiol. 264 (1993) H1693-H1700
19. Kohrman D.C., and Imperiale M.J. Simian virus 40 large T antigen stably complexes with a 185-kilodalton host protein. J. Virol. 66 (1992) 1752-1760
20. Ali S.H., Kasper J.S., Arai T., and DeCaprio J.A. Cul7/p185/p193 binding to simian virus 40 large T antigen has a role in cellular transformation. J. Virol. 78 (2004) 2749-2757
21. Kasper J.S., Kuwabara H., Arai T., Ali S.H., and DeCaprio J.A. Simian virus 40 large T antigen's association with the CUL7 SCF complex contributes to cellular transformation. J. Virol. 79 (2005) 11685-11692
22. Nikolaev A.Y., Li M., Puskas N., Qin J., and Gu W. Parc: a cytoplasmic anchor for p53. Cell 112 (2003) 29-40
23. Skaar J.R., Arai T., and DeCaprio J.A. Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development. Mol. Cell Biol. 25 (2005) 5579-5589
24. Grossberger R., Gieffers C., Zachariae W., Podtelejnikov A.V., Schleiffer A., Nasmyth K., Mann M., and Peters J.M. Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex. J. Biol. Chem. 274 (1999) 14500-14507
25. Zalvide J., and DeCaprio J.A. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell Biol. 15 (1995) 5800-5810
26. Arai T., Skaar J.R., Ali S.H., Takahashi C., and DeCaprio J.A. Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 9855-9860
27. Poulin D.L., and DeCaprio J.A. p53 targets simian virus 40 large T antigen for acetylation by CBP. J. Virol. 78 (2004) 8245-8253
28. Stubdal H., Zalvide J., and DeCaprio J.A. Simian virus 40 large T antigen alters the phosphorylation state of the RB-related proteins p130 and p107. J. Virol. 70 (1996) 2781-2788
29. Frangioni J.V., and Neel B.G. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210 (1993) 179-187
30. Kominami K., Seth-Smith H., and Toda T. Apc10 and Ste9/Srw1, two regulators of the APC-cyclosome, as well as the CDK inhibitor Rum1 are required for G1 cell-cycle arrest in fission yeast. Embo. J. 17 (1998) 5388-5399
31. Ji Y., Rebert N.A., Joslin J.M., Higgins M.J., Schultz R.A., and Nicholls R.D. Structure of the highly conserved HERC2 gene and of multiple partially duplicated paralogs in human. Genome Res. 10 (2000) 319-329
32. Hochrainer K., Mayer H., Baranyi U., Binder B., Lipp J., and Kroismayr R. The human HERC family of ubiquitin ligases: novel members, genomic organization, expression profiling, and evolutionary aspects. Genomics 85 (2005) 153-164
33. Andrews P., He Y.J., and Xiong Y. Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function. Oncogene (2006)
34. Gu J., Nie L., Kawai H., and Yuan Z.M. Subcellular distribution of p53 and p73 are differentially regulated by MDM2. Cancer Res. 61 (2001) 6703-6707
35. Bode A.M., and Dong Z. Post-translational modification of p53 in tumorigenesis. Nat. Rev. Cancer 4 (2004) 793-805
36. Linzer D.I., and Levine A.J. Characterization of a 54 K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17 (1979) 43-52
37. Linzer D.I., Maltzman W., and Levine A.J. The SV40 A gene product is required for the production of a 54,000 MW cellular tumor antigen. Virology 98 (1979) 308-318
38. Tebar F., Sorkina T., Sorkin A., Ericsson M., and Kirchhausen T. Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits. J. Biol. Chem. 271 (1996) 28727-28730